Cost of Revenue of bioAffinity Technologies, Inc. from 30 Jun 2022 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
bioAffinity Technologies, Inc. quarterly and annual Cost of Revenue in USD history and change rate from 30 Jun 2022 to 30 Sep 2023.
  • bioAffinity Technologies, Inc. Cost of Revenue for the quarter ending 30 Sep 2023 was $74,704, a 51067% increase year-over-year.
Source SEC data
View on sec.gov
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)

bioAffinity Technologies, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $74,704 +$74,558 +51067% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $1,234 +$1,088 +745% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $87 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q3 2022 $146 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $146 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2

bioAffinity Technologies, Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $467 01 Jan 2022 31 Dec 2022 10-K 31 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.